Gain Therapeutics Inc. (GANX) Fail-to-Deliver (FTD) Analysis | Settlement Risk & Short Interest - Stocknear

Gain Therapeutics Inc.

NASDAQ: GANX · Real-Time Price · USD
1.73
0.02 (1.17%)
At close: Sep 10, 2025, 3:59 PM
1.72
-0.58%
After-hours: Sep 10, 2025, 05:04 PM EDT

Gain Therapeutics Fail-to-Deliver

Total FTD Shares
5K
Below Average
FTD / Avg. Volume
1.30%
Low Impact
1-Year Change
> 100%
Positive Trend

FTD Chart

As of Jul 29, 2025, Gain Therapeutics Inc. has 5,000 shares failed to deliver, representing 1.30% of the average daily volume of 385,995 shares.

FTD History

Date Price FTD Shares % Change
Jul 29, 2025 1.57 5,000 +438.21%
Jun 26, 2025 1.99 929 -27.31%
Apr 25, 2025 1.9 1,278 -14.80%
Jan 23, 2025 2.23 1,500 +50.00%
Dec 19, 2024 1.57 1,000 +16.82%
Nov 26, 2024 1.73 856 -95.35%
Oct 31, 2024 2.5 18,412 +2201.50%
Sep 30, 2024 1.78 800 -99.22%
Aug 30, 2024 1.09 102,683 +8261.81%
Jul 31, 2024 1.08 1,228 -99.84%
Jun 28, 2024 1.28 785,623 +257481.31%
May 06, 2024 2.85 305 +52.50%
Apr 30, 2024 2.93 200 +589.66%
Mar 27, 2024 3.73 29 -96.62%
Feb 23, 2024 4.55 857 +12142.86%
Jan 18, 2024 3.36 7 -99.56%
Dec 29, 2023 3.27 1,577 +157600.00%
Nov 10, 2023 2.74 1 -99.91%
Oct 05, 2023 3.22 1,083 +65.34%
Sep 26, 2023 3.2 655 -96.24%
Jul 17, 2023 4.49 17,406 +16320.75%
Jun 30, 2023 4.48 106 -1.85%
May 30, 2023 4.59 108 +285.71%
Apr 21, 2023 5.43 28 -99.62%
Mar 31, 2023 4.82 7,300 +173.92%
Feb 28, 2023 4.16 2,665 -54.91%
Jan 31, 2023 3.95 5,910 n/a